Drawing for CMC DATAFACTORY

USPTO serial 79435823

CMC DATAFACTORY

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MARTYNOV,VIKTORIIA V
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with CMC DATAFACTORY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher R. Butler

Christopher R. Butler HAHN LOESER & PARKS LLP200 Public Square, Suite 2800Cleveland, OH 44114United States

Goods and services

ClassDescriptionStatusFirst use
009Scientific apparatus and instruments, namely, data processing equipment, laboratory robots, and autonomous robotic systems for scientific and laboratory use; research apparatus and instruments, namely, pharmaceutical and scientific research equipment for use in the development and manufacturing of pharmaceutical products; measuring apparatus and instruments, namely, electronic apparatus for measuring physical, chemical, and biological parameters in pharmaceutical and chemical manufacturing processes; detecting apparatus and instruments, namely, electronic apparatus for detecting physical, chemical, and biological parameters in pharmaceutical and chemical manufacturing processes; testing apparatus and instruments, namely, quality control robots, electronic apparatus, and machines for testing pharmaceutical products; inspecting apparatus and instruments, namely, quality control robots, electronic apparatus, and machines for inspecting pharmaceutical products; electronic manufacturing controls systems for industrial and pharmaceutical manufacturing machines; electronic testing and quality control equipment, namely, sensing and testing devices for measurement and quality control of pharmaceutical products; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; recorded multimedia files containing text, audio and video relating to artificial intelligence, machine learning, collaborative robotics and automated systems in the field of pharmaceutical development, manufacture and supply; recorded multimedia files containing text, audio, and video relating to artificial intelligence, machine learning, collaborative robotics, and automated systems in the field of pharmaceutical development, pharmaceutical manufacture, and pharmaceutical supply; downloadable multimedia files containing text, audio and video relating to the field of chemistry, manufacturing, and controls, pharmaceutical development, manufacture, and supply; downloadable multimedia files containing text, audio, and video in the field of chemistry, manufacturing, and controls, pharmaceutical development, pharmaceutical manufacture, and pharmaceutical supply; downloadable computer software incorporating artificial intelligence and machine learning for the optimisation of chemical and pharmaceutical development and manufacturing processes; downloadable computer software incorporating artificial intelligence and machine learning for the optimisation of chemical and pharmaceutical development processes and chemical and pharmaceutical manufacturing processes; computers and computer peripheral devices; downloadable computer software for data management, scientific and industrial process control, quality assurance in the field of pharmaceutical development, pharmaceutical manufacture, and pharmaceutical supply, and regulatory compliance auditing; downloadable computer software for managing business or scientific processes; downloadable computer-aided manufacturing (CAM) software for pharmaceutical use; downloadable computer aided manufacturing (CAM) software for use in pharmaceutical development, pharmaceutical manufacture, and pharmaceutical design; downloadable scientific and industrial process controlling softwareACTIVE—
041Educational services, namely, conducting classes, seminars, conferences, and workshops in the field of chemistry, manufacturing, and controls, pharmaceutical development, pharmaceutical manufacture, and pharmaceutical supply; providing of training in the field of chemistry, manufacturing, and controls, pharmaceutical development, pharmaceutical manufacture, and pharmaceutical supply; manufacturing training services; education services, namely, conducting classes, seminars, conferences and workshops in the field of chemistry; training services in the field of chemistry; education services, namely, conducting classes, seminars, conferences, and workshops in the field of chemistry processes and controls; training services in the field of chemistry processes and controls; education, namely, conducting classes, seminars, conferences, and workshops relating to manufacture of pharmaceuticals; training services relating to manufacture of pharmaceuticalsACTIVE—
042Scientific and technological services, namely, scientific and technological research, analysis, and testing in the field of chemistry, manufacturing and controls; scientific research and design relating to the aforementioned services; research and development services in the field of pharmaceutical development, pharmaceutical manufacture, and pharmaceutical supply; research and development services in the field of chemistry; scientific research relating to chemistry; scientific research for medical purposes in the field of pharmaceutical development, pharmaceutical manufacture, and pharmaceutical supply; medical research services; medical and pharmacological research services; chemistry consultation services; consultancy relating to pharmaceutical research and development; consultancy and information service relating to research and development of pharmaceutical products; industrial analysis, namely, analysis of pharmaceutical products and pharmaceutical development processes, and pharmaceutical manufacturing processes; industrial research in the field of pharmaceutical development, pharmaceutical manufacturing, and pharmaceutical supply; industrial design services; testing services in the field of chemistry, manufacturing, and controls, pharmaceutical development, pharmaceutical manufacture, and pharmaceutical supply; quality authentication services, namely, authenticating pharmaceutical products, pharmaceutical development processes, and pharmaceutical manufacturing processes; quality control services for others; pharmaceutical product quality testing services; product safety testing and consultation; consultancy related to quality control of goods and services; process monitoring for quality assurance in the field of pharmaceutical development, pharmaceutical manufacture, and pharmaceutical supply; design and development of computer hardware and software; providing online non downloadable software for scientific and industrial process control, quality assurance in the field of pharmaceuticals, and regulatory compliance auditing; providing temporary use of non-downloadable software for managing business and scientific processes; providing temporary use of non-downloadable software for industrial process management; computer programming in the pharmaceutical field; development of computer software for computer aided design and computer aided pharmaceutical manufacturingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 6, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 6, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 30, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 9, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 11, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 11, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 11, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 5, 2026ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Aug 5, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 5, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 5, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 5, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 26, 2026RFNTREFUSAL PROCESSED BY IB—
Feb 11, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 11, 2026RFRRREFUSAL PROCESSED BY MPU—
Jan 15, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 14, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 6, 2026DOCKASSIGNED TO EXAMINER—
Nov 3, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 3, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 30, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance